VS
Velusamy Senthilkumar
About Velusamy Senthilkumar
Data last updated:
Velusamy Senthilkumar is a Director at Medinews Pharma India Private Limited (since 2012) and Partner at Gudimangalam Water Project Llp (since 2024). The companies operate in E-Commerce. The largest current company by reported revenue is Medinews Pharma India Private Limited at ₹55.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medinews Pharma India Private Limited U24230TZ2011PTC017444 | Director | 21 Feb 2012 | 2011 | ₹55.2 Lakh (FY 2024) | Active |
 Gudimangalam Water Project Llp ACF-6338 | Partner | 20 Sep 2024 | 2024 | Active |
Board colleagues of Velusamy Senthilkumar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Velusamy Senthilkumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Velusamy Senthilkumar
Velusamy Senthilkumar currently holds 2 directorships: Medinews Pharma India Private Limited (Director, since 21 Feb 2012, revenue ₹55.2 Lakh (FY 2024)); Gudimangalam Water Project Llp (Partner, since 20 Sep 2024).
Velusamy Senthilkumar was first appointed on 21 Feb 2012 as Director at Medinews Pharma India Private Limited. The most recent appointment on record is 20 Sep 2024 at Gudimangalam Water Project Llp.
The current boards of Velusamy Senthilkumar's companies include Chinnaraj Mailerravindran (Medinews Pharma India Private Limited), Duraisamy Gounder Kandaswami (Medinews Pharma India Private Limited), Gopalsamy Ravindran (Medinews Pharma India Private Limited), Kirubakaran Kondaiyampalayam Ranganathan (Medinews Pharma India Private Limited), Kodikalpalayam Abulhasan Mohammedyusuf (Medinews Pharma India Private Limited), Namasivayam Veerasivam (Medinews Pharma India Private Limited), among others.